1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow lanifibranor: new trials by email Literature Review of lanifibranor trials Research Report on lanifibranor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) IVA337, Placebo - NASH - Nonalcoholic Steatohepatitis | Phase 3 | Active not recruiting | Inventiva Pharma | 1000 | 2021-08-19 | 2026-11-02 |
Fibrosis (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1)
Inventiva Pharma (1)
Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Mexico (1)
Arun J Sanyal, MD (1) · Sven Francque, MD (1)